Research Library

Home » Research Library » D9-Tetrahydrocannabinol (THC) » Neuroprotection by D9 -Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity

Neuroprotection by D9 -Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity

Journal: The Journal of Neuroscience
Publication Year: 2001
Authors: M. van der Stelt; W. B. Veldhuis; P. R. Bär; G. A. Veldink; J. F. G. Vliegenthart; K. Nicolay

Abstract

Excitotoxicity is a paradigm used to explain the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. Here, we show in a longitudinal magnetic resonance imaging study that 9 -tetrahydrocannabinol (9 -THC), the main active compound in marijuana, reduces neuronal injury in neonatal rats injected intracerebrally with the Na /K -ATPase inhibitor ouabain to elicit excitotoxicity. In the acute phase 9 -THC reduced the volume of cytotoxic edema by 22%. After 7 d, 36% less neuronal damage was observed in treated rats compared with control animals. Coadministration of the CB1 cannabinoid receptor antagonist SR141716 prevented the neuroprotective actions of 9 -THC, indicating that 9 -THC afforded protection to neurons via the CB1 receptor. In 9 -THC-treated rats the volume of astrogliotic tissue was 36% smaller. The CB1 receptor antagonist did not block this effect. These results provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.

Loading cart ...
X